01177 中國生物製藥
公司資料 - 損益表
中國生物製藥有限公司 股票編號: 01177
SINO BIOPHARMACEUTICAL LTD. 集團網址: http://www.sinobiopharm.com
2024/12 - 末期
人民幣(K¥)
變動 2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
營業額 / 收益28,866,15910.179%26,199,40928,780,41226,861,35623,647,224
銷售成本(5,336,218)6.941%(4,989,877)(5,795,510)(5,332,095)(5,182,320)
毛利23,529,94110.940%21,209,53222,984,90221,529,26118,464,904
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值------------
出售項目溢利 / (虧損)------------
其他非經營項目------------
分佔聯營公司及共同控制公司業績(118,299)-77.497%(525,710)(152,976)13,630,790(3,233)
除稅前溢利 / (虧損)5,277,468-2.448%5,409,9065,778,60418,572,6735,013,044
稅項(492,918)-38.174%(797,267)(775,986)(1,957,880)(672,377)
已終止經營業務溢利 / (虧損)1,580,132225.962%484,759------
非控股權益(2,864,848)3.594%(2,765,459)(2,459,048)(2,006,381)(1,569,581)
其他項目------------
股東應佔溢利 / (虧損)3,499,83450.083%2,331,9392,543,57014,608,4122,771,086
 
淨財務支出 / (收入)(204,447)--116,902237,617146,560129,365
折舊及攤銷1,321,18127.442%1,036,6951,046,984992,5561,654,836
董事酬金----203,407227,139176,656170,783
 
核數師意見無保留意見--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)19.130--12.59013.66077.83014.740
每股派息 (仙)6.530--4.53410.5056.4886.141
派息比率 (%)34.134%--36.015%76.904%8.336%41.664%
每股現金流 ($)----0.3270.3360.2860.283
每股帳面資產淨值 ($)1.701--1.6211.5811.6080.888
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.